Fed. Circ. Nixes Inventor's Anti-Coagulant Patent App
The Federal Circuit rejected a challenge Thursday to a U.S. Patent and Trademark Office decision that sustained the invalidity of an application for a patent covering segments of the heparin molecule...To view the full article, register now.
Already a subscriber? Click here to view full article